Shining on Major News: Twitter Inc (NYSE:TWTR), Ohr Pharmaceutical (NASDAQ:OHRP), Oracle Corporation (NYSE:ORCL), Pandora Media Inc (NYSE:P), Starwood Property Trust (NYSE:STWD)

On Friday shares of Twitter Inc (NYSE:TWTR) closed at $37.10. Company’s EPS growth for next 5 years is recorded as 69.13%. TheStreet lowered shares of Twitter Inc. (NYSE:TWTR) from a hold rating to a sell rating in a research report released on Wednesday morning.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity decreased -0.73% to close at $2.73. Company weekly performance is -0.73% while its quarterly performance stands at -63.01%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -77.82% away from its 52 week high. Ohr Pharmaceutical Inc. (NASDAQ:OHRP) on 11 May, reported a loss of $3.4 million in its fiscal second quarter. On a per-share basis, the New York-based company said it had a loss of 12 cents. In the final minutes of trading on Monday, the company’s shares hit $2.74. A year ago, they were trading at $6.87.

Oracle Corporation (NYSE:ORCL) in last trading activity moved down -0.52% to close at $44.15. Company weekly performance is 0.32% while its quarterly performance stands at 0.85%. Oracle Corporation (NYSE:ORCL) is -4.89% away from its 52 week high. Oracle Corporation (NYSE:ORCL) recently hired a team of engineers from Nebula, a computing startup that stopped operating in April. Around 40 engineers joined the cloud-computing group of Oracle. These engineers will report to the Snapchat and Google veteran, Peter Magnusson, who joined Oracle last year as senior VP, cloud development.

On last trading day Pandora Media Inc (NYSE:P) moved down -2.66% to close at $18.31. Its volatility for the week is 3.39% while volatility for the month is 4.13%. P’s sales growth for past 5 years was 75.60%. Pandora Media Inc (NYSE:P) monthly performance is 2.18%. Pandora Media Inc (NYSE:P) said it will appeal a rate court ruling that could force the company to pay higher royalties to Broadcast Music Inc (BMI) for music licenses.

On last trading day Starwood Property Trust, Inc. (NYSE:STWD) decreased -0.45% to close at $24.27. Its volatility for the week is 1.15% while volatility for the month is 1.06%. STWD’s sales growth for past 5 years was 152.10% and its EPS growth for past 5 years was 108.40%. Starwood Property Trust, Inc. (NYSE:STWD) monthly performance is 1.42%. On 6 May, Starwood Property Trust, Inc. (NYSE:STWD) has reported a marginal fall of 0.20 percent in profit for the quarter ended Mar. 31, 2015. The company has earned $120.36 million, or $0.52 a share, compared with $120.60 million or $0.60 a share, a year ago. Revenue during the quarter grew 3.99 percent to $178.85 million from $171.98 million in the previous year period.

Today’s Hot List: Ohr Pharmaceutical (NASDAQ:OHRP), Ardelyx (NASDAQ:ARDX), RingCentral (NYSE:RNG), Harris Corporation (NYSE:HRS), Kraton Performance Polymers Inc. (NYSE:KRA)

On Monday shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) closed at $2.74. On May 11, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), reported results for its second fiscal quarter ended March 31, 2015. General and administrative expenses from operations increased to approximately $3.6 million from approximately $1.3 million in same period in 2014. Research and development expenses increased to approximately $2.9 million compared to approximately $608 thousand in the same period in 2014.

Ardelyx, Inc. (NASDAQ:ARDX) in last trading activity moved up 1.58% to close at $9.00. Company weekly performance is -17.88% while its quarterly performance stands at -43.36%. Ardelyx, Inc. (NASDAQ:ARDX) is -3.17% away from its 52 week high. On May 5, Ardelyx, Inc. (NASDAQ:ARDX), announced that a 154-patient Phase 2a clinical trial evaluating tenapanor in Stage 3 chronic kidney disease patients with type 2 diabetes mellitus and albuminuria did not meet the primary endpoint of decreasing the urinary albumin-creatinine ratio in tenapanor-treated patients compared to patients receiving placebo.

On last trading day RingCentral, Inc. (NYSE:RNG) moved up 0.29% to close at $17.09. Its volatility for the week is 2.60% while volatility for the month is 3.00%. RingCentral, Inc. (NYSE:RNG) monthly performance is 2.89%. RingCentral, Inc. (NYSE:RNG), announced the company will be presenting at .P. Morgan 2015 Global Technology, Media and Telecom Conference in Boston, MA on Monday, May 18, 2015.

Harris Corporation (NYSE:HRS) has 0.14% insider ownership while its institutional ownership stands at 86.50%. In last trading activity company’s stock closed at $78.26. Harris Corporation (NYSE:HRS) has reported an 11.10 percent fall in profit for the quarter ended Apr. 03, 2015. The company has earned $125.70 million, or $1.20 a share in the quarter, compared with $141.40 million, or $1.31 a share for the same period last year.

On last trading day Kraton Performance Polymers Inc. (NYSE:KRA) moved up 1.37% to close at $23.65. Its volatility for the week is 2.81% while volatility for the month is 2.57%. KRA’s sales growth for past 5 years was 4.90% and its EPS growth for past 5 years was 55.20%. Kraton Performance Polymers Inc. (NYSE:KRA) monthly performance is 17.90%. on May 6, 2015 Kraton Performance Polymers, Inc. (NYSE:KRA), announced it will present two technical presentations on its polymer technologies during Chinaplas on May 20-23, 2015 in Guangzhou, China.

Fast Moving Stocks: Ohr Pharmaceutical (NASDAQ:OHRP), Ariad Pharmaceuticals (NASDAQ:ARIA), Yingli Green Energy Holding Co. (NYSE:YGE), Renren Inc. (NYSE:RENN), Cyan (NYSE:CYNI)

On Tuesday shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) closed at $2.82. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) announced the details of two podium presentations at the forthcoming Association for Research in Vision and Ophthalmology (ARVO) Conference, that will take place at the Colorado Convention Center in Denver, CO, May 3 – 7.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) shares moved down -2.71% in last trading session and ended the day at $8.99. ARIA Gross Margin is 95.10% and its return on assets is -33.80%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) quarterly performance is 39.38%. On 29 April, Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) said Chief Executive Harvey Berger would retire as part of a deal to settle a proxy battle with its largest shareholder Sarissa Capital Management.

On last trading day Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) moved down -2.69% to close at $1.81. Its volatility for the week is 2.83% while volatility for the month is 4.22%. YGE’s sales growth for past 5 years was 12.20% and its EPS growth for past 5 years was -14.30%. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) monthly performance is -2.69%. Equities researchers at Wolfe Research started coverage on shares of Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) in a research report issued on Thursday. The firm set an “underperform” rating on the stock.

Renren Inc. (NYSE:RENN) has 7.91% insider ownership while its institutional ownership stands at 3.20%. In last trading activity company’s stock closed at $2.91. On 29 April, Renren Inc. (NYSE:RENN) announced the results of its previously announced Dutch auction tender offer to purchase for cash up to $50 million in value of its American Depositary Shares (the “ADSs”), each representing three Class A ordinary shares of the Company, par value $0.001 per share, at a purchase price not greater than $2.75 per ADS nor less than $2.40 per ADS.

On last trading day Cyan, Inc. (NYSE:CYNI) moved down -1.95% to close at $4.53. Its volatility for the week is 4.34% while volatility for the month is 3.30%. Cyan, Inc. (NYSE:CYNI) monthly performance is 6.84%. Cyan, Inc. (NYSE:CYNI) announced that it has added a number of new partners to Blue Orbit, its ecosystem of partners focused on delivering applications and infrastructure platforms for real-world multi-vendor SDN and NFV deployments.

Worth Watching Stocks: Ohr Pharmaceutical (NASDAQ:OHRP), Cempra (NASDAQ:CEMP), Xenoport (NASDAQ:XNPT), Preferred Apartment Communities (NYSEMKT:APTS), Neurocrine Biosciences Inc. (NASDAQ:NBIX)

On Thursday shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) closed at $2.81. Ohr Pharmaceuticals, Inc. (NASDAQ: OHRP) recently announced disappointing top line results from the exploratory Phase II IMPACT study evaluating OHR-102 (0.2% Squalamine lactate ophthalmic solution) combination therapy for the treatment of the wet form of age-related macular degeneration (wet-AMD).

Cempra, Inc. (NASDAQ:CEMP) in last trading activity fell -6.72% to close at $31.49. Company weekly performance is -18.82% while its quarterly performance stands at 12.58%. Cempra, Inc. (NASDAQ:CEMP) is -24.36% away from its 52 week high. It was reported on 27 April, that Cempra Inc.(NASDAQ:CEMP) is in line for a $10 million milestone when the Japanese drug regulating authority processes a patent on Cempra’s experimental pneumonia treatment. This would be the second $10 milliontranche received by Cempra from Toyama Chemical Company, a subsidiary of FUJIFILM Holdings Corporation, though is still less than one-third of the total potential value of the partnership.

On last trading day Xenoport, Inc. (NASDAQ:XNPT) fell -9.05% to close at $5.93. Its volatility for the week is 8.44% while volatility for the month is 5.09%. XNPT’s sales growth for past 5 years was 6.50% and its EPS growth for past 5 years was 18.90%. Xenoport, Inc. (NASDAQ:XNPT) monthly performance is -16.71%. XenoPort Inc. (NASDAQ:XNPT) was upgraded by Zacks from a “hold” rating to a “buy” rating in a note issued to investors on Thursday.

Preferred Apartment Communities, Inc. (NYSEMKT:APTS) has 1.30% insider ownership while its institutional ownership stands at 37.60%. In last trading activity company’s stock closed at $11.06. Preferred Apartment Communities, Inc. (NYSEMKT:APTS) announced plans to release its first quarter 2015 earnings after the market closes on Monday, May 4, 2015.

On last trading day Neurocrine Biosciences Inc. (NASDAQ:NBIX) fell -8.19% to close at $34.09. Its volatility for the week is 8.93% while volatility for the month is 5.64%. NBIX’s EPS growth for past 5 years was 9.00%. Neurocrine Biosciences Inc. (NASDAQ:NBIX) monthly performance is -14.15%.Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Deutsche Bank 40th Annual Health Care Conference in Boston. The live presentation takes place on Thursday, May 7 at 11:20am ET (8:20am PT).

Today’s Stocks: Itau Unibanco Holding (NYSE:ITUB), Ohr Pharmaceutical (NASDAQ:OHRP), Illumina Inc. (NASDAQ:ILMN), Yingli Green Energy Holding (NYSE:YGE), Trina Solar (NYSE:TSL)

On Wednesday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $11.45. Company’s sales growth for last 5 years was 10.60% and EPS growth for next 5 years is recorded as 12.10%. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) announced to stockholders and to the market in general that the Board of Directors at meeting held on March 26, 2015, registered a proposal for resolution at the Extraordinary General Meeting to be held on April 29, 2015 at 3:05 p.m.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity increased 0.39% to close at $2.55. Company weekly performance is -71.32% while its quarterly performance stands at -69.46%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -82.53% away from its 52 week high. On March 30, Ohr Pharmaceutical Inc. (NASDAQ:OHRP) announced results from its Phase II study of OHR-102 combination therapy for the treatment of the wet form of age-related macular degeneration Friday morning. The study failed to meet its primary endpoint.

On last trading day Illumina Inc. (NASDAQ:ILMN) moved down -1.85% to close at $182.21. Its volatility for the week is 2.64% while volatility for the month is 2.79%. ILMN’s sales growth for past 5 years was 22.80% and its EPS growth for past 5 years was 34.90%. Illumina Inc. (NASDAQ:ILMN) monthly performance is -7.05%. BTIG Research set a $240.00 target price on Illumina Inc (NASDAQ:ILMN) in a report issued on Tuesday. The firm currently has a a buy rating on the stock.

On Wednesday shares of Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) closed at $1.87. Company’s sales growth for last 5 years was 12.20%. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE), or Yingli Solar, a manufacturer of solar modules, has reported that net loss attributable to the company for the fourth quarter ended December 31, 2014 was RMB550.05 million, or RMB3.03 loss per share, compared to net loss attributable to the company of RMB776.21 million, or RMB4.95 loss per share, for the same quarter ended December 31, 2013. Total net revenues for the fourth quarter ended December 31, 2014 were RMB3.45 billion, compared to RMB3.71 billion, for the same quarter ended December 31, 2013.

Trina Solar Limited (NYSE:TSL) in last trading activity moved up 3.23% to close at $12.48. Company weekly performance is 3.40% while its quarterly performance stands at 46.31%. Trina Solar Limited (NYSE:TSL) is -17.62% away from its 52 week high. Trina Solar Limited (NYSE:TSL) announced that it has entered into a set of binding agreements, including a Share Purchase Agreement (the “SPA”) and a Bridge Loan Facility Agreement, with Bluefield Solar Income Fund Limited for the Company’s 49.99 MW solar power plant in Norfolk, UK, for a maximum consideration of approximately GBP59.1 million (equivalent to approximately $87.7 million) with a retention of GBP3 million (equivalent to approximately $4.4 million) contingent on certain conditions under the SPA.

Investors Watch List: Regulus Therapeutics Inc. (NASDAQ:RGLS), Orexigen Therapeutics (NASDAQ:OREX), Ohr Pharmaceutical (NASDAQ:OHRP), 3M Company (NYSE:MMM)

On Monday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $17.26. Company’s EPS growth for next 5 years is recorded as 39.60%. Regulus Therapeutics Inc. (NASDAQ:RGLS) ‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a report released on Wednesday. They currently have a $41.00 price objective on the stock. Wedbush’s target price points to a potential upside of 148.18% from the stock’s previous close.

On Monday shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) closed at $7.75. Company’s sales growth for last 5 years was 253.90% and EPS growth for next 5 years is recorded as 20.00%. On 26 March, Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced that the European Commission has granted marketing authorization for Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (≥18 years) with an initial Body Mass Index (BMI) of ≥ 30 kg/m2 (obese), or ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co-morbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension). This authorization applies to all 28 European Union (EU) member states.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity increased 2.55% to close at $2.81. Company weekly performance is -70.36% while its quarterly performance stands at -67.25%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -80.75% away from its 52 week high. On 27 March, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, wiping out two-thirds of the company's market value on Friday.

On last trading day 3M Company (NYSE:MMM) increased 1.56% to close at $166.05. Its volatility for the week is 1.54% while volatility for the month is 1.39%. MMM's sales growth for past 5 years was 6.60% and its EPS growth for past 5 years was 10.60%. 3M Company (NYSE:MMM) monthly performance is -1.54%. On 26 March, 3M Company (NYSE:MMM) said that, SOFTlab collaborated with 3M and BBDO to realize 3M’s ‘lifelab’ pavilion at SXSW festival 2015.

Investor’s Choice: Ohr Pharmaceutical (NASDAQ:OHRP), Southwestern Energy (NYSE:SWN), Gaming and Leisure Properties (NASDAQ:GLPI), AcelRx Pharmaceuticals (NASDAQ:ACRX), Simon Property Group Inc. (NYSE:SPG)

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) announced that Dr. Irach Taraporewala, Chief Executive Officer, presented a corporate overview and business update at the 35th Annual Cowen & Company Health Care Conference, on Wednesday, March 4. On Monday shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) closed at $10.75.

Fitch Ratings has assigned Southwestern Energy Company (NYSE:SWN) an ‘F3’ Short-term Issuer Default Rating (IDR). In addition, Fitch rates Southwestern’s $2 billion commercial paper program ‘F3’. Southwestern Energy Co. (NYSE:SWN) in last trading activity moved down -5.75% to close at $22.29. Company weekly performance is -10.73% while its quarterly performance stands at -27.13%. Southwestern Energy Co. (NYSE:SWN) is -54.66% away from its 52 week high.

Gaming and Leisure Properties, Inc (NASDAQ:GLPI) offered Monday to acquire the real estate assets of Pinnacle Entertainment, Inc. for GLPI shares in a deal having an enterprise value of $4.1 billion, including assumption of debt. GLPI noted that the offer is unanimously approved by its Board of Directors, and fully endorsed by its senior management team. On Monday shares of Gaming and Leisure Properties, Inc (NASDAQ:GLPI) closed at $36.43. Company’s EPS growth for next 5 years is recorded as 46.75%.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) reported financial results for the three and twelve months ended December 31, 2014. Net loss for the fourth quarter of 2014 was $13.8 million, or $0.32 basic and diluted net loss per share, compared to $17.8 million net income, or $0.41 basic net income per share and $0.39 diluted net income per share, for the fourth quarter of 2013. AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) in last trading activity decreased -36.96% to close at $5.51. Company weekly performance is -39.65% while its quarterly performance stands at -13.50%. AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is -58.88% away from its 52 week high.

Simon Property Group Inc. (NYSE:SPG)’s unsolicited bid to buy Macerich Co. for more than $20 billion shows how enticing a top-flight U.S. mall business can be at a time when other parts of the retail real estate industry are struggling. On last trading day Simon Property Group Inc. (NYSE:SPG) decreased -0.08% to close at $180.44. Its volatility for the week is 1.51% while volatility for the month is 1.82%. SPG’s sales growth for past 5 years was 5.20% and its EPS growth for past 5 years was 29.30%. Simon Property Group Inc. (NYSE:SPG) monthly performance is -10.57%.

Big Movers in Focus: Lattice Semiconductor Corporation (NASDAQ:LSCC), Ohr Pharmaceutical (NASDAQ:OHRP), General Motors Company (NYSE:GM), Google Inc (NASDAQ:GOOGL), Citigroup Inc. (NYSE:C)

Lattice Semiconductor Corporation (NASDAQ:LSCC) on 2 March 2015, made the following announcements related to its proposed acquisition of Silicon Image (NASDAQ:SIMG). As previously announced, Lattice Semiconductor has entered into a definitive agreement to acquire Silicon Image, and commenced a tender offer on February 9, 2015 for all outstanding shares of Silicon Image for $7.30 per share in cash. On Friday shares of Lattice Semiconductor Corporation (NASDAQ:LSCC) closed at $6.76. Company’s sales growth for last 5 years was 13.50% and EPS growth for next 5 years is recorded as 20.00%.

Formerly on March 2, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), an ophthalmology research and development corporation, declared the presentation of new data from the INFLUENCE study interim analysis at the 38th Annual Macula Society Meeting which took place February 25-28th, in Scottsdale, Arizona. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity moved up 0.44% to close at $11.48. Company weekly performance is 49.28% while its quarterly performance stands at 36.18%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -42.60% away from its 52 week high.

General Motors Co (NYSE:GM) is expected to announce a share-buyback program on Monday in order to avoid an eventual proxy fight with activist investor Harry J. Wilson, who has been pushing for a seat on the carmaker’s board, the Wall Street Journal reported. On last trading day General Motors Company (NYSE:GM) moved down -2.05% to close at $36.84. Its volatility for the week is 1.34% while volatility for the month is 1.45%. GM’s sales growth for past 5 years was 8.30% and its EPS growth for past 5 years was -57.00%. General Motors Company (NYSE:GM) monthly performance is 2.82%.

Google Inc (NASDAQ:GOOGL) and Skyhook Wireless Inc. settled a dispute involving global positioning detection patents, according to a March 5 court filing. Google Inc (NASDAQ:GOOGL) has 0.10% insider ownership while its institutional ownership stands at 81.40%. In last trading activity company’s stock closed at $572.90.

ING cut shares of Citigroup (NYSE:C) from a sector perform rating to an underperform rating in a research note issued to investors. On last trading day Citigroup Inc. (NYSE:C) moved down -0.93% to close at $53.06. Its volatility for the week is 1.64% while volatility for the month is 1.67%. C’s sales growth for past 5 years was 5.20% and its EPS growth for past 5 years was 18.00%. Citigroup Inc. (NYSE:C) monthly performance is 9.63%.

Top Movers: Cognex Corporation (NASDAQ:CGNX), Ohr Pharmaceutical (NASDAQ:OHRP), United Security Bancshares Inc. (NASDAQ:USBI), Home Bancorp (NASDAQ:HBCP), Gilead Sciences Inc. (NASDAQ:GILD)

Canaccord Genuity reiterated their buy rating on shares of Cognex Corporation (NASDAQ:CGNX) in a research note released on Wednesday morning. They currently have a $55.00 target price on the stock. On Monday shares of Cognex Corporation (NASDAQ:CGNX) closed at $47.02. Company’s sales growth for last 5 years was 22.60% and EPS growth for next 5 years is recorded as 13.00%.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), announced the presentation of new data from the IMPACT study interim analysis at the 38th Annual Macula Society Meeting which took place February 25-28th, in Scottsdale, Arizona. The new data show an early regression of subretinal hyper-reflective material (SHRM), an anatomic biomarker for the wet form of age-related macular degeneration (wet-AMD), which is consistent with the early gains in visual acuity previously reported from this study. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity moved up 27.18% to close at $9.78. Company weekly performance is 38.14% while its quarterly performance stands at 28.68%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -51.10% away from its 52 week high.

United Securities Bancshares (NASDAQ: USBI) declared a quarterly dividend of $0.02 per share, or $0.08 annualized. The dividend will be payable on April 1, 2015, to stockholders of record on March 12, 2015, with an ex-dividend date of March 10, 2015.On last trading day United Security Bancshares Inc. (NASDAQ:USBI) moved down -0.18% to close at $8.29. Its volatility for the week is 0.66% while volatility for the month is 0.67%. USBI’s sales growth for past 5 years was -7.90% and its EPS growth for past 5 years was -6.30%. United Security Bancshares Inc. (NASDAQ:USBI) monthly performance is -1.36%.

Home Bancorp, Inc. (NASDAQ: HBCP), announced that the Bank has converted from a federal savings bank charter to a national bank charter. The Bank’s legal name is now “Home Bank, National Association” and the Company is now a bank holding company. Home Bancorp, Inc. (NASDAQ:HBCP) has 4.00% insider ownership while its institutional ownership stands at 35.30%. In last trading activity company’s stock closed at $21.42.

On 26 February, Gilead Sciences, Inc. (NASDAQ:GILD) announced detailed 48-week results from two Phase 3 studies (Studies 104 and 111) evaluating its investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults. On last trading day Gilead Sciences Inc. (NASDAQ:GILD) moved up 0.29% to close at $103.83. Its volatility for the week is 1.39% while volatility for the month is 2.12%. GILD’s sales growth for past 5 years was 28.80% and its EPS growth for past 5 years was 39.10%. Gilead Sciences Inc. (NASDAQ:GILD) monthly performance is -0.34%.

Best Stocks: Nokia Corporation (ADR) (NYSE:NOK), Ohr Pharmaceutical (NASDAQ:OHRP), Borderfree (NASDAQ:BRDR), Netlist Inc. (NASDAQ:NLST), Pfizer Inc. (NYSE:PFE)

Notice has been given to the shareholders of Nokia Corporation Corporation (ADR) (NYSE:NOK) of the Annual General Meeting to be held on Tuesday, May 5, 2015 at 4:00 p.m. at Helsinki Messukeskus, Messuaukio 1, Helsinki, Finland. On Tuesday shares of Nokia Corporation (ADR) (NYSE:NOK) closed at $8.04. Company’s sales growth for last 5 years was -20.80% and EPS growth for next 5 years is recorded as 16.20%.

On 9 February, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) reported a net loss of approximately $4.6 million, or $0.18 per share For the first quarter ended December 31, 2014, compared with $2.0 million, or $0.10 per share, in the first quarter of 2013. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) in last trading activity advanced 0.68% to close at $7.43. Company weekly performance is 6.45% while its quarterly performance stands at -0.27%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) is -62.85% away from its 52 week high.

Borderfree Inc. (NASDAQ: BRDR) reported Q4 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $36.7 million versus the consensus estimate of $38.61 million. Borderfree sees Q1 2015 EPS of ($0.15)-($0.12), versus the consensus of ($0.08). On last trading day Borderfree, Inc. (NASDAQ:BRDR) moved down -1.30% to close at $6.07. Its volatility for the week is 4.94% while volatility for the month is 5.79%. Borderfree, Inc. (NASDAQ:BRDR) monthly performance is -13.66%.

Netlist, Inc. (NASDAQ:NLST), announced that it has amended the credit financing agreement it entered in July 2013 with an affiliate of Fortress Investment Group LLC (FIG), a leading global investment management firm. Netlist Inc. (NASDAQ:NLST) has 15.22% insider ownership while its institutional ownership stands at 11.00%. In last trading activity company’s stock closed at $1.68.

On 13 February, Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application (NDA) for ALO-02 extended-release capsules, an abuse-deterrent formulation (ADF) opioid for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. On last trading day Pfizer Inc. (NYSE:PFE) moved down -0.17% to close at $34.58. Its volatility for the week is 1.69% while volatility for the month is 2.09%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 7.66%.